PAA 0.00% 19.5¢ pharmaust limited

Ann: First Patient of Cohort 2 Dosed in MND Trial, page-66

  1. 11,748 Posts.
    lightbulb Created with Sketch. 5949
    Roger should be presenting not just attending , he is the CEO of an Australian Listed Biotech specialising in K9 Cancer Treatments.

    All of the Companies will be eagerly watching the presentations , seems extremely reasonable , more than likely stimulate considerable interest in Pharmaust ..
    https://hotcopper.com.au/data/attachments/5075/5075205-24fe6dae9b9dc2a1acd282fe7594e6df.jpg

 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
(20min delay)
Last
19.5¢
Change
0.000(0.00%)
Mkt cap ! $86.55M
Open High Low Value Volume
19.5¢ 19.5¢ 18.5¢ $330.4K 1.741M

Buyers (Bids)

No. Vol. Price($)
1 4071 19.0¢
 

Sellers (Offers)

Price($) Vol. No.
19.5¢ 24580 3
View Market Depth
Last trade - 16.10pm 28/06/2024 (20 minute delay) ?
PAA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.